Bio Pharma Supply Chain Strategy Amid US Tariff Policy Shifts US tariffs and the most favored nation pricing order are reshaping pharmaceutical supply chains, driving up API and freight costs while squeezing margins. Leading drugmakers are responding through rapid financial disclosure, domestic manufacturing investments, and diversified sourcing to manage risk.